血乙卡尼丁和氨基酸在失脂症:一个综合的代谢学和机器学习方法
Ali Etemadi1,2, Farima Hassanzadehkiabi2, Maryam Mirabolghasemi3
1Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
机器学习模型可以准确地预测失脂症患者的甘油三水平. 特定的氨基酸和甲酸被确定为关键指标,以区分高甘油三的病例与正常对照.
科学领域:
- 生物化学 生物化学
- 医疗信息学 医疗信息学
- 公共卫生 公共卫生
背景情况:
- 脱脂症是心血管疾病的重要危险因素.
- 了解失脂症的潜在生化中间体对于有效的管理至关重要.
- 目前的诊断和治疗策略需要根据更深入的病理生理学的见解进行改进.
研究的目的:
- 为了确定与失脂症相关的关键代谢中间体.
- 开发和验证机器学习模型,用于分类失脂症亚型.
- 提高对失脂症病理生理学的理解,以改善预防和治疗.
主要方法:
- 利用了来自伊朗非传染性疾病 (NCD) 风险因素监测 (STEPs 2016) 的数据.
- 在1200名受试者中分析了20种氨基酸和30种甲酸的血度,使用双重质谱法.
- 应用机器学习算法,包括支持矢量机器 (SVM),以根据甘油三水平分类正常和异常病例.
主要成果:
- 机器学习框架证明了对三甘 (TG) 二元类的准确预测,SVM模型实现了0.81.8的AUC.
- 确定了包括氨酸,氨酸,氨酸,C3,C14:2和C16在内的特定代谢物,作为高TG的显著差异化因素.
- 该模型有效地区分了高TG和正常TG控制的个体.
结论:
- 机器学习模型,特别是SVM,在根据代谢概况对失脂症的分类方面表现有前途.
- 特定的氨基酸和甲酸是识别失脂症的有价值生物标志物.
- 结合性别特征的进一步研究可以加深对失脂症中间体的理解,并为治疗策略提供信息.
更多相关视频
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
06:16Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
Published on: July 28, 2023
相关概念视频
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacogenomics: Identification of New Drug Targets
Lipid Catabolism
